Subclinical Vascular Disease Burden and Longer Survival Public Deposited

http://ir.library.oregonstate.edu/concern/articles/x346d9387

This is an author's peer-reviewed final manuscript, as accepted by the publisher. The article is copyrighted by the authors; the Journal compilation is copyrighted by the American Geriatrics Society and published by John Wiley & Sons, Inc. It can be found at:  http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291532-5415

Descriptions

Attribute NameValues
Creator
Abstract or Summary
  • OBJECTIVES: Subclinical vascular disease (SVD) contributes to the aging process and may decrease life expectancy. We aimed to determine the contribution of gradations of SVD to the likelihood of achieving longer survival, and to determine what allows some individuals to achieve longer survival in the presence of high SVD. DESIGN: Cohort Study SETTING: Cardiovascular Health Study PARTICIPANTS: Adults who were born after June 30th, 1918 and before June 30th, 1921 (n=2,082); participants were age 70-75 years at baseline visit (1992-1993). MEASUREMENTS: A SVD index was scored as 0, 1, or 2 for no, mild, or severe abnormalities on ankle-arm index, electrocardiogram, and common carotid intima-media thickness measured at baseline. Survival groups were categorized as <80, 80-84, 85-89, and 90+ years. RESULTS: A one point lower SVD score was associated with a 1.22 (95% confidence interval: 1.14, 1.31) higher odds of achieving longer survival, independent of potential confounders. This association was unchanged after adjustment for intermediate incident cardiovascular events. There was suggestion of an interaction of kidney function, smoking, and CRP with SVD; the association of SVD and longer survival appeared modestly increased in persons with poor kidney function, inflammation, or a history of smoking. CONCLUSION: A lower burden of SVD is associated with longer survival, and this association was independent of intermediate cardiovascular events. Abstinence from smoking, better kidney function, and lower inflammation may attenuate the effects of higher SVD and further promote longer survival.
Resource Type
DOI
Date Available
Date Issued
Citation
  • Odden, M. C., Yee, L. M., Arnold, A. M., Sanders, J. L., Hirsch, C., deFilippi, C., ... & Newman, A. B. (2014). Subclinical Vascular Disease Burden and Longer Survival. Journal of the American Geriatrics Society, 62(9), 1692-1698. doi:10.1111/jgs.13018
Series
Keyword
Rights Statement
Funding Statement (additional comments about funding)
Publisher
Peer Reviewed
Language
Replaces

Relationships

In Administrative Set:
Last modified: 11/02/2017 Default
Citations:

EndNote | Zotero | Mendeley